LOS ANGELES, Nov. 9 /PRNewswire-FirstCall/ -- Paul Castillo, M.D., M.PH., today joins telemedicine and network communication company Veridigm (OTC Bulletin Board:ENSY) (formerly eNotes Systems, Inc.) as its Chief Medical Officer. In his new capacity, Dr. Castillo will oversee the implementation of Veridigm's telemedicine technology and will serve as the company's primary conduit to the professional medical community. Dr. Castillo will also lead the company's clinical development in collaboration with Dr. Michael Gallagher, Veridigm's Medical Director and Medical Advisory Board Chairman.
Dr. Castillo has nearly two decades of experience in clinical and preventive medicine. After training at the University of Washington School of Medicine and Johns Hopkins University, Dr. Castillo launched a unique career focused on reliably articulating and integrating the space between medicine and technology. He worked as a clinical technology consultant to the US Congress and as Medical Director for a Rand-based venture to build top flight software used to manage chronic diseases. Dr. Castillo is a member of the American College of Preventive Medicine, the American College of Medical Quality and the American College of Physician Executives.
"Dr. Castillo's experience in large IT implementations in multi-hospital settings and executive contacts in both payer and provider communities brings crucial experience and thought leadership to Veridigm," says Jeff Flammang, Veridigm's President and Chief Executive Officer. "His leadership in the telemedicine sector is a natural evolution from many years of hard won experience in the IT environment."
"It is essential for the healthcare industry to understand and accept that an effective connective technology is a critical next step in healing a deeply fragmented system," adds Dr. Castillo. "Veridigm's technology goes well beyond real-time connectivity by more powerfully integrating the relationship between provider and patient."
A telemedicine, network communication and data transmission company based in Los Angeles, California, Veridigm enables doctors, healthcare providers, and patients in disparate locations to interact, exchange and display complex diagnostic data in both audio and video formats, in real-time and in complete privacy. Helping to overcome the geographic and financial barriers keeping countless rural patients from receiving proper care from remote urban health specialists while facilitating communication among multi-segments of the healthcare community, Veridigm develops, markets, and sells its proprietary telemedicine products and services to major hospitals, medical facilities, and other healthcare-related centers throughout North America and eventually worldwide. For more information please visit www.veridigm.com.
Forward-Looking Statement: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from acquisitions or actions in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties, and factors include, but are not limited to, future capital needs, changes, and delays in product development plans and schedules, or market acceptance.